Orchestra BioMed Holdings, Inc. SEC filings OBIO

Orchestra BioMed Holdings, Inc. has 412 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Jun 16, 2026 —
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 23, 2026
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 24, 2025
DEFA14A Additional proxy material Apr 30, 2024 —
DEF 14A Proxy statement Apr 30, 2024 Jun 20, 2024
DEFA14A Additional proxy material Jul 18, 2022 —
DEFA14A Additional proxy material Jul 12, 2022 —
DEF 14A Proxy statement Jul 1, 2022 Jul 26, 2022
PRE 14A Preliminary proxy statement Jun 21, 2022 Jun 21, 2022

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
OBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Hope, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1814114
Former names
Health Sciences Acquisitions Corp 2 (until Jan 26, 2023)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.